NCT01532700
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +14 more
- Locations
-
- University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada
Clinical trial condition
Chronic Lymphocytic Leukemia (CLL)
Explore clinical trials studying Chronic Lymphocytic Leukemia (CLL). Study availability and eligibility vary by location and protocol.
72 public trials
20 recruiting studies
Chronic Lymphocytic Leukemia (CLL) trial results
NCT02226861
- Conditions
- Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Bone Marrow Diseases, +24 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT00614042
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +17 more
- Locations
-
- For additional information regarding sites for this trial call 919-319-9374 Birmingham, Alabama, United States
- For additional information regarding sites for this trial call 919-319-9374 Augusta, Georgia, United States
- For additional information regarding sites for this trial call 919-319-9374 Boston, Massachusetts, United States
- For additional information regarding sites for this trial call 919-319-9374 Las Vegas, Nevada, United States
NCT01466153
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +17 more
- Locations
-
- Research Site Birmingham, Alabama, United States
- Research Site Burbank, California, United States
- Research Site La Jolla, California, United States
- Research Site Palm Springs, California, United States
NCT01580228
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +14 more
- Locations
-
Not specified
Completed
Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL)
NCT01520922
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +17 more
- Locations
-
- Novartis Investigative Site Tuscon, Arizona, United States
- Novartis Investigative Site Aurora, Colorado, United States
- Novartis Investigative Site Fort Myers, Florida, United States
- Novartis Investigative Site St. Petersburg, Florida, United States
NCT01527838
- Conditions
- Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Chronic Disease, +26 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana Farber Cancer Institute-Hematopoietic Stem Cell Transplant Program Boston, Massachusetts, United States
- Ohio State Univeristy Comprehensive Cancer Center Columbus, Ohio, United States
NCT01413568
- Conditions
- Acute Myeloid Leukemia in Remission, Adult Acute Lymphoblastic Leukemia in Remission, Blood Protein Disorders, +36 more
- Locations
-
- University of Kansas Cancer Center Kansas City, Kansas, United States
- Washington University School of Medicine St Louis, Missouri, United States
NCT01419691
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +17 more
- Locations
-
- University of Kansas Cancer Center Westwood, Kansas, United States
NCT00694590
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +15 more
- Locations
-
- UCSD Moores Cancer Center La Jolla, California, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
- UTMD Anderson Cancer Center Houston, Texas, United States